The ftc wants martin shkreli held in contempt – Breaking News & Latest Updates 2026
Skip to main content
M
External Link
The FTC wants Martin Shkreli held in contempt.

According to the regulator, the so-called “Pharma Bro” hasn’t been complying with its investigation into whether his new company, Druglike, Inc, violates his ban from working in the pharmaceutical industry. A press release calls Druglike “a Web3 drug discovery software platform,” which definitely seems like something the world needs.

Follow topics and authors from this story to see more like this in your personalized homepage feed and to receive email updates.
Comments
Loading comments
Getting the conversation ready...